Ventana Medical Systems
Carrie Aldrich is an experienced professional in the field of molecular biology and genetics, currently serving as a Project Lead at Ventana Medical Systems since January 2011. Prior to this role, Carrie worked at Roche Molecular Systems for nearly a decade, where responsibilities included serving as a Principal Scientist leading research on cervical cancer diagnostics and contributing to the development of a real-time PCR assay for high-risk Human Papillomavirus. Carrie's academic background includes a Ph.D. in Genetics from the University of Chicago and a B.S. in Microbiology from Colorado State University.
Ventana Medical Systems
Ventana Medical Systems, Inc., a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company’s intuitive, integrated staining and workflow management platforms that optimize laboratory efficiencies to reduce errors – support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, Ventana is driving personalized healthcare through accelerated drug discovery and the development of “companion diagnostics” to identify the patients most likely to respond favorably to specific therapies. Visit www.ventana.com to learn more.